Reuters logo
BRIEF-TherapeuticsMD announces plan to resubmit the new drug application for TX-004HR
2017年11月6日 / 上午11点17分 / 16 天前

BRIEF-TherapeuticsMD announces plan to resubmit the new drug application for TX-004HR

Nov 6 (Reuters) - TherapeuticsMD Inc

* TherapeuticsMD Inc announces plan to resubmit the new drug application for TX-004HR

* TherapeuticsMD Inc - Division of bone,reproductive & urologic products, US FDA agreed to NDA resubmission for TX-004HR without additional pre-approval study​

* TherapeuticsMD Inc - ‍on Nov 3 co participated in an in-person meeting with division of bone, reproductive, and urologic products of US FDA​

* TherapeuticsMD Inc - ‍co will commit to conduct a post-approval observational study​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below